Drug profile

The FDA adverse-event record for Canine Adenovirus Type 2, Strain Manhattan, 12-13-76;Canine Distemper Virus, Str

454 adverse-event reports submitted to the FDA Center for Veterinary Medicine reference Canine Adenovirus Type 2, Strain Manhattan, 12-13-76;Canine Distemper Virus, Str. See the species affected, top reactions, and outcomes below.

454
adverse-event reports
10.4%
death-coded share
Dog
most-reported species
157
Vomiting - top reaction
Verify with FDA CVM →
Important: Adverse event reports do not establish that a drug caused or contributed to the event. Consult your veterinarian before making treatment decisions.
454
Total Reports
47
Deaths Reported
10.4%
Death Rate

Active Ingredients

Canine Adenovirus Type 2, Strain Manhattan, 12-13-76;Canine Distemper Virus, Str

Administration Routes

SubcutaneousUnknownOral

Species Affected

Dog 454

Most Affected Breeds

Chihuahua 32
Retriever - Golden 32
Retriever - Labrador 30
Dachshund (unspecified) 22
Terrier - Bull - American Pit 21
Crossbred Canine/dog 21
Schnauzer - Miniature 17
Bulldog - French 15
Boxer (German Boxer) 14
Terrier (unspecified) 14

Most Reported Reactions

Vomiting 157
Lethargy (see also Central nervous system depression in Neurological) 103
Facial swelling (see also Skin) 75
Anaphylaxis 60
Diarrhoea 52
Pale mucous membrane 45
Not eating 43
Hives (see also Skin) 43
Seizure NOS 34
Fever 33
Emesis (multiple) 33
Death 30

Outcome Breakdown

Ongoing
241 (53.1%)
Recovered/Normal
137 (30.2%)
Died
32 (7.0%)
Outcome Unknown
29 (6.4%)
Euthanized
15 (3.3%)

Canine Adenovirus Type 2, Strain Manhattan, 12-13-76;Canine Distemper Virus, Str Adverse Event Insights

454 reports name Canine Adenovirus Type 2, Strain Manhattan, 12-13-76;Canine Distemper Virus, Str; 47 recorded a death outcome (10.4% of reported events, not a population-level mortality rate). Active ingredient: Canine Adenovirus Type 2, Strain Manhattan, 12-13-76;Canine Distemper Virus, Str. Administration routes: Subcutaneous, Unknown, Oral.

By species: Dog (454 reports). By breed: Chihuahua (32), Retriever - Golden (32), Retriever - Labrador (30).

Leading clinical signs: Vomiting (157), Lethargy (see also Central nervous system depression in Neurological) (103), Facial swelling (see also Skin) (75), Anaphylaxis (60). Outcome, 454 coded reports: Ongoing leads at 53.1%.

Read these counts as reporting volume, not risk: per our methodology, a widely-prescribed drug will rack up more raw FDA reports in a given year than a rarely-used one at an identical true rate, so we recommend comparing within similar-exposure products rather than across the full 2025 catalog.

Source: FDA Center for Veterinary Medicine openFDA Animal & Veterinary Adverse Events (CVM AER) · 2025

Every figure on PlainBreed is rendered directly from FDA openFDA adverse event data, no number is typed in by an editor. This page draws directly on FDA openFDA data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.